MENU
+Compare
INM
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$2.91
Change
-$0.14 (-4.59%)
Capitalization
9.19M

INM InMed Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company... Show more

INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INM with price predictions
Jul 03, 2025

INM in upward trend: 10-day moving average broke above 50-day moving average on June 26, 2025

The 10-day moving average for INM crossed bullishly above the 50-day moving average on June 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on June 24, 2025. You may want to consider a long position or call options on INM as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INM just turned positive on June 24, 2025. Looking at past instances where INM's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

INM moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day RSI Indicator for INM moved out of overbought territory on June 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INM broke above its upper Bollinger Band on June 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for INM entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.372) is normal, around the industry mean (16.672). P/E Ratio (0.014) is within average values for comparable stocks, (58.456). INM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.448) is also within normal values, averaging (269.644).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKX57.002.60
+4.78%
POSCO Holdings
BRY3.100.04
+1.31%
Berry Corp
APPN30.480.34
+1.13%
Appian Corp
HCWB4.06-0.11
-2.64%
HCW Biologics Inc
MSPR1.02-0.06
-5.56%
MSP Recovery Inc

INM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-4.59%
TTNP - INM
44%
Loosely correlated
+1.15%
EYEN - INM
39%
Loosely correlated
N/A
OMER - INM
36%
Loosely correlated
+3.56%
VTYX - INM
31%
Poorly correlated
+2.97%
PULM - INM
30%
Poorly correlated
-6.71%
More

Groups containing INM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-4.59%
Pharmaceuticals
category (297 stocks)
-4%
Poorly correlated
+0.50%